PFS
EDIT icon

Prospera Financial Services’s Editas Medicine EDIT Stock Holding History

Prospera Financial Services’s Portfolio EDIT Stock Details EDIT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-260
Closed -$3K – 1035
2022
Q2 		$3K Sell
260
-425
-62% -$5.7K ﹤0.01% 1509
2022
Q1 		$13K Buy
+685
New +$12.7K ﹤0.01% 1913
2021
Q1 		– Sell
-4,334
Closed -$304K – 749
2020
Q4 		$304K Buy
+4,334
New +$178K 0.02% 535

Other funds holding EDIT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Two Sigma Advisers
Two Sigma Advisers New York $51.4B AUM 31.07% 1-Year Est. Return

Prospera Financial Services's EDIT Position: Q3 2022 in Review

Prospera Financial Services sold out of Editas Medicine (EDIT) in Q3 2022, closing a stake of 260 shares — an estimated $3K sold.

Prospera Financial Services first reported a position in EDIT in Q4 2020 and held it in 3 quarters. The position peaked at $304K in Q4 2020. 264 funds tracked by Wall St. Rank hold EDIT as of Q3 2022.

  • Prospera Financial Services reported no remaining Editas Medicine position as of Q3 2022 after selling out during the quarter.
  • Prospera Financial Services sold 260 Editas Medicine shares in Q3 2022, an estimated $3K.
  • Prospera Financial Services first reported a position in Editas Medicine in Q4 2020 and held it in 3 quarters.
  • Prospera Financial Services's Editas Medicine position peaked at $304K in Q4 2020.
  • 264 funds tracked by Wall St. Rank held Editas Medicine as of Q3 2022.

Based on Prospera Financial Services's 13F filing for Q3 2022, filed 27 Oct 2022.